A Study to See if Clinical Cardiac MRI Scanning Can Cause DNA Damage

Overview

About this study

The long-term goal of this research program is to clarify the potential mutation causing and cancer causing risk posed by clinical magnetic resonance imaging (MRI).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Adults, >18 years
  • Scheduled to undergo any elective cardiac MR, cardiac CT, or echocardiogram exam at Mayo

Exclusion Criteria

  • History of malignancy
  • Received radiation therapy or chemotherapy immediately prior to exam
  • Had immunosuppressant drugs at the time of their exam
  • Underwent any MR or CT  within 7 days prior to their exam

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Jennifer McDonald, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions